Dijk Marcus Antonius van is Chief Scientific Officer of MiNK Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | INKT MiNK Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.87 | 171,078 | 148.84 k | 171,078 |
16 Jan 24 | INKT MiNK Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.87 | 15,000 | 13.05 k | 15,000 |
9 Jan 23 | INKT MiNK Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.32 | 15,000 | 34.80 k | 15,000 |
9 Jan 23 | INKT MiNK Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.32 | 24,265 | 56.29 k | 27,363 |
9 Jan 23 | INKT MiNK Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.32 | 51,628 | 119.78 k | 51,628 |